Our Community

Diabetes is relentless and unpredictable.
Our hope is that InsuJet™ can help you live an unstoppable life. These personal stories from the people empowered by InsuJet™ show how needle-free technology can give you the power to change how you live with diabetes.

Ukraine Support

Many of the roughly 2.5M #Ukrainians living with #diabetes require daily #insulin injections to survive, our latest coalition aims to deliver insulin injections to those in high-conflict areas of the country in a quick & safe manner. Medical Response #Drones will be used to deliver InsuJet™ needle-free injection devices, pre-loaded with #insulin, to dangerous and hard-to-reach areas across #Ukraine.

Testimonials

4.5 | User Survey 2022 >

"The device is easy to transport and handle, even on trips or travels."

Peter J.

Germany

" The absence of needle sharps definitely contributes to overal safety.
The device is easy to transport and handle , even on trips or travels.

The biggest benefit of the InsuJet™ is to be needle-free."

"No more needles!"

Dr. Richard Gallo

Canada

"It's not just for the patients but it's also for the practitioners. The nurses the physicians. No more needles!

Having a safer working environment is key. And this product offers that."

"InsuJet™ makes the insulin spread much better under the skin, and prevents you from getting lumps on your skin."

Birger William

Norway

"I would like other people to know that InsuJet™ is a very good device, and is very easy to use.💖

Now with the InsuJet™ I can inject myself in much bigger areas than with the ordinary needle.

InsuJet™ makes the insulin spread much better under the skin, and prevents you from getting lumps on your skin.

Needles gave me pain very often. The biggest benefit of InsuJet™ is no needle in my skin😀💖💖💖💖!"

"InsuJet™ is extremely safe to use. And very easy."

Dr. Nadeem Siddiqui

Canada

edecec

Use this section to explain a set of percercs. Add images for emphasis.

Example title

Use this section to explain a set of product features, to link to a series of pages, or to answer common questions about your products. Add images for emphasis.

Example title

Use this section to explain a set of product features, to link to a series of pages, or to answer common questions about your products. Add images for emphasis.

Example title

Join The Community.

You can make a difference to join InsuJet™ and help life-changing experiences happen.

Contact us.

Have a question?

Offices

InsuJet™ looks forward to hearing from you.

Corporate Address:

InsuJet™ EPG BV
Euro Offices Building 3rd floor, Beechavenue 127, 1119 RB Schiphol -Rijk, The Netherlands

NL:+31-20-360-140

InsuJet™ NuGen MD
18 King Street East, Suite 1400
Toronto, Ontario M5C 1C4 Canada

CA:+1-833-285-2666

Mon - Fri
09:30am - 17:00pm (Local time)

Email: info@insujet.com

Send a message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TGA

ISO 13485

CE CERTIFIED

HEALTH CANADA

NHS

Disclaimers:

01. Compatible insulin types: Human and animal; Fast acting insulins (bolus); Rapid Acting Insulin Analogs; Regular Human Insulin; Basal insulins; Intermediate-acting, commonly: NPH/ Isophane; Long-acting, commonly: Glargine, detemir, degludec; Premixtures (e.g. 30/70).

    02. In a user survey, 78% of respondents answered they would recommend InsuJet™ to others.

    03. In a user survey, 40% of the respondents answered they noticed using less insulin.

    04. Needle-Free Jet Injection of Rapid-Acting Insulin Improves Early Postprandial Glucose Control in Patients With Diabetes. Diabetes Care, October 2013.

    05. Body mass index and the efficacy of needle-free jet injection for the administration of rapid-acting insulin analogs, a post hoc analysis. Diabetes, Obesity and Metabolism, July 2012.

    06. Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology. Diabetes Care, August 2011

    07. A Pilot Study to Examine the Tolerability and Device Preference in Type 1 Diabetes of Insulin Apart Administered by InsuJet™ Compared with Subcutaneous Injection. Diabetes Technology & Therapeutics, 2014.

    08. See medical deck Cost Analysis - North America, 2022 available on the Partner page.

    09. Calculated at 4 injections a day with a hypodermic needle. 4 injection a day, every day of the year, adds up to 1,460 needles a year saved from use.   

    *. The InsuJet™ is calibrated for U-100 insulins

    **. Needle gauge 26-27 is commonly used for subcutaneous injections and is around 0.40 - 0.45mm in diameter. The orifice of the InsuJet™ Nozzle is about 0.15mm in diameter which is much smaller than conventional needle gauges used for subcutaneous insulin injections.

    ***. https://pubmed.ncbi.nlm.nih.gov PMID:18820853